agilon health, inc. (AGL)

Every figure this model derived for AGL, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2026-06-30.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 12,691,000 PaymentsToAcquirePropertyPlantAndEquipment 2026-06-30
cash 529,676,000 CashAndCashEquivalentsAtCarryingValue 2026-06-30
current assets 1,418,534,000 AssetsCurrent 2026-06-30
current liabilities 1,312,349,000 LiabilitiesCurrent 2026-06-30
equity 227,527,000 StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest 2026-06-30
interest expense 6,973,000 InterestExpenseNonoperating 2026-06-30
ocf -72,260,000 NetCashProvidedByUsedInOperatingActivities 2026-06-30
revenue 5,920,015,000 RevenueFromContractWithCustomerExcludingAssessedTax 2026-06-30
sbc 47,105,000 ShareBasedCompensation 2026-06-30

The ratios

The figures themselves rather than their scores — what somebody looking up AGL on one particular measure came for.

RatioValue
cash operating margin-3.96
current ratio1.08
current ratio reported1.08
dilution pct0.73
ev owner earnings-8.19
ev sales0.18
fcf margin-1.43
growth cv0.7
interest cover-44.36
operating margin-5.23
owner earnings margin-2.23
revenue growth0.32
revenue growth per share-0.41
rule of 40-4.91
sbc pct revenue0.8

What to be careful about

What this model itself distrusts about AGL's figures. Written by the derivation as it ran, not added afterwards.